<DOC>
	<DOCNO>NCT01540162</DOCNO>
	<brief_summary>EcN registered medical drug brand name Mutaflor® SUSPENSION Ukraine 2010 . Indications clinical use acute diarrhea infant toddler include tube feeding tube , diarrhea child , prophylactic pathological colonization newborn include premature newborn , improvement immunity newborn ( mature premature ) . The aim trial observe efficacy safety Mutaflor® SUSPENSION use immunity improvement preterm newborn infant</brief_summary>
	<brief_title>Experience Mutaflor Suspension Use Preterm Infants Immunity Improvement</brief_title>
	<detailed_description>Study design : open-labeled , control , parallel group , non-interventional 3-weeks-study follow prospective observation 1 week 1 year follow-up period . Patients group I take probiotic Mutaflor orally dose 1 ml day first week life three time per week second third week life . Patients group II n't take specific probiotic immunity strengthening .</detailed_description>
	<criteria>age 1224 hour life ; 1st degree prematurity ( functionally mature infant , gestational age 3536 week ) ; exclusive breast feeding study ; parent must sign date inform consent infant 's participation study . perinatal asphyxia ( Apgar score less 8 ) ; significant concomitant disease ( congenital birth defect , perinatal encephalopathy , TORCH infections infectious disease newborn , respiratory distress syndrome ets ) ; clinically significant change blood analyze result ( need ) ; use probiotic prebiotics first 28 day study participation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>preterm newborn</keyword>
	<keyword>neonatology</keyword>
	<keyword>EcN</keyword>
	<keyword>Nissle</keyword>
	<keyword>Mutaflor</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>infection</keyword>
</DOC>